A Randomized Open-Label Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated with Daily or Weekly Bisphosphonates

  • Muse, Kenneth (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date9/1/09 → 10/31/11